Package 71610-965-53

{"route": ["ORAL"], "spl_id": "445e0469-117c-0ed5-e063-6394a90abe40", "openfda": {"unii": ["86P6PQK0MU"], "rxcui": ["197627"], "spl_set_id": ["445dc831-1960-4b25-e063-6294a90a6efd"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (71610-965-53)", "package_ndc": "71610-965-53", "marketing_start_date": "20251121"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (71610-965-60)", "package_ndc": "71610-965-60", "marketing_start_date": "20251121"}, {"sample": false, "description": "120 TABLET in 1 BOTTLE (71610-965-70)", "package_ndc": "71610-965-70", "marketing_start_date": "20251121"}], "brand_name": "Doxazosin mesylate", "product_id": "71610-965_445e0469-117c-0ed5-e063-6394a90abe40", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "71610-965", "generic_name": "doxazosin mesylate", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxazosin mesylate", "active_ingredients": [{"name": "DOXAZOSIN MESYLATE", "strength": "4 mg/1"}], "application_number": "NDA019668", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20250924", "listing_expiration_date": "20261231"}